Skip to content

Total Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$86.48B-6.4%
Eli Lilly logo
Eli LillyLLY
$116.58B+30.4%
Amgen logo
AmgenAMGN
$92.5B+3.5%
Incyte logo
IncyteINCY
$7.34B+27.7%
AbbVie logo
AbbVieABBV
$136.46B+0.2%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE

Other financials

Income statement

See full
Revenue$56.4M+99.0%
Operating income-$3.6M+81.1%
Net income$3.8M+132%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$193.7M+38.7%
Total debt$9.8M-13.9%
Total equity$655.5M-4.9%

Cash flow

See full
Operating cash flow-$48.9M-139%
CapEx$215.0K-60.6%
Free cash flow-$49.2M-139%

Valuation

See full
Market cap$7.26B+127%
Enterprise value$7.07B+130%
P/S98×+82.6×

Profitability

See full
Operating margin-192.4%-205pp
Net margin-154.9%-182pp
FCF margin-12,264.3%-12,527pp

Returns & leverage

See full
Return on equity-17.1%-26.1pp
Debt / equity0.0×
Current ratio17.8×+0.5×

Where this comes from

Reported directly by Protagonist Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Protagonist Therapeutics's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Protagonist Therapeutics's total assets?
Protagonist Therapeutics (PTGX) reported total assets of $697.46M in Q1 2026.
How has Protagonist Therapeutics's total assets changed year-over-year?
Protagonist Therapeutics's total assets decreased by 6.0% year-over-year, from $742.13M to $697.46M.
What is the long-term trend for Protagonist Therapeutics's total assets?
Over 5 years (2020 to 2025), Protagonist Therapeutics's total assets has grown at a 15.5% compound annual growth rate (CAGR), from $324.47M to $668.19M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.